Table 1 Small-molecule drugs used in the Liver-Chip evaluation.

From: Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology

Drug

IQ MPS list

Tested in spheroid

Spheroid false negative

Garside DILI rank

Ambrisentan

Yes, matched with Sitaxsentan

Yes

No

5

Asunaprevir

Yes, no matched pair

No

No

2

Benoxaprofen

No

Yes

Yes

1

Beta-Estradiol

No

Yes

Yes

3

Buspirone

Yes, matched with Nefazodone

Yes

No

4

Chlorpheniramine

No

Yes

Yes

3

Clozapine

Yes, matched with Olanzapine

Yes

No

2

Diclofenac

Yes, no matched pair

Yes

No

2

Entacapone

Yes, matched with Tolcapone

Yes

No

4

Fialuridine

Yes, matched with FIRU

Yes

No

1

FIRU

Yes, matched with Fialuridine

No

No

5

Labetalol

No

Yes

Yes

1

Levofloxacin

Yes, matched with Trovafloxacin

Yes

Yes

2

Lomitapide

No, Mipomersen substitute

No

No

3

Nefazodone

Yes, matched with Buspirone

Yes

No

1

 

Yes, matched with Clozapine

No

No

5

Pioglitazone

Yes, matched with Troglitazone

Yes

Yes

3

Simvastatin

No

Yes

Yes

2

Sitaxsentan

Yes, matched with Ambrisentan

Yes

No

1

Stavudine

No

Yes

Yes

1

Tacrine

No

Yes

Yes

2

Telithromycin

Yes, no matched pair

No

No

1

Tolcapone

Yes, matched with Entacapone

Yes

No

1

Troglitazone

Yes, matched with Pioglitazone

Yes

No

1

Trovafloxacin

Yes, matched with Levofloxacin

Yes

No

1

Ximelagatran

No

Yes

Yes

1

Zileuton

Yes, no matched pair

Yes

Yes

2

  1. The 27 small-molecule drugs are listed according to the IQ MPS affiliate classification and their ranking in the Garside DILI severity category, where 1 corresponds to drugs with severe clinical DILI and 5 to those with no DILI31,50. Structurally related toxic and non-toxic pairs are indicated as well using bold, italic text.